Impact of COVID-19 on people with cystic fibrosis

The Lancet Respiratory Medicine

Volumn 8, Issue 5, 2020, Pages e35-e36

  Colombo, Carla ^a   Burgel, Pierre Régis ^b   Gartner, Silvia ^c   van Koningsbruggen Rietschel, Silke ^d   Naehrlich, Lutz ^e   Sermet Gaudelus, Isabelle ^b   Southern, Kevin W ^f  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CHINA; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CORONAVIRUS DISEASE 2019; COUGHING; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SEVERITY; E-MAIL; EUROPE; EXERCISE; FEAR; FEVER; GOVERNMENT; HAND WASHING; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH SERVICE; HUMAN; INFECTION RISK; INFLUENZA A VIRUS (H1N1); ITALY; LETTER; LONG TERM CARE; LUNG CLEARANCE; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MORBIDITY; MYALGIA; OXYGEN SATURATION; PANDEMIC; PATIENT ISOLATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RESPIRATORY FAILURE; SELF MONITORING; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOCIAL BEHAVIOR; SOCIAL DISTANCE; SPIROMETRY; TELECONSULTATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION; VOLUNTEER; BETACORONAVIRUS; CORONAVIRUS INFECTION; ISOLATION AND PURIFICATION; PATHOPHYSIOLOGY; VIROLOGY; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; CYSTIC FIBROSIS; EUROPE; HUMANS; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85083497770     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(20)30177-6     Document Type: Letter

References (7)

1. Guan, W-J, Ni, Z-Y, Hu, Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020 published online Feb 28. DOI:10.1056/NEJMoa2002032.
2. Remuzzi, A, Remuzzi, G, COVID-19 and Italy: what next?. Lancet, 2020 published online March 13. https://doi.org/10.1016/S0140-6736(20)30627-9.
3. Bell, SC, Mall, MA, Gutierrez, H, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med 8 (2020), 65–124.
4. Colombo, C, Battezzati, PM, Lucidi, V, et al. Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study. Thorax 66 (2011), 260–261.
5. Bucher, J, Boelle, P-Y, Hubert, D, et al. Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy. BMC Infect Dis, 16, 2016, 55.
6. European Medicines Agency. Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic: version 2. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf, March 27, 2020. (Accessed 8 April 2020)
7. Nacoti, M, Ciocca, A, Giupponi, A, et al. At the epicenter of the COVID-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catal, 2020 published online March 21. DOI:10.1056/CAT.20.0080.